Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card

2021/02/17 by Garrett A. Perchetti, Meei‐Li Huang, Margaret G. Mills +2 · 1 citation
Medicine · Engineering · #SARS-CoV-2 detection and testing #SARS-CoV-2 and COVID-19 Research #Biosensors and Analytical Detection

paper · doi:10.1128/jcm.02880-20

openalex publication_date 2021/02/17 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31

Abstract

Multiple rapid antigen (Ag) tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have recently received emergency-use authorization (EUA) from the U.S. Food and Drug Administration (FDA).

Citations

• Virological assessment of hospitalized patients with COVID-2019

Cited by

• Abbott Laboratories [wikipedia]

Related

• Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing
• Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
• Contextual analysis of the first SARS-CoV-2 RNA screening period in nasopharyngeal swabs, 2020-2022: a comparison of two diagnostic tests
• Diagnostics for SARS-CoV-2 infections
• How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available